iPS Cell Production Using Cell Scaffold Adhesion Selection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for producing induced pluripotent stem cells (iPS cells) are complex and time-consuming, often requiring additional steps to recover suspended somatic cells and may not yield cells of favorable quality, such as high TRA-1-60 expression, within a short period.
Innovation Solution
A production method involving a seeding step on a cell culture substrate with a cell scaffold, followed by removing non-adhered somatic cells and introducing a reprogramming factor to adhered cells, utilizing a peptide-conjugated resin with a synthetic resin moiety and peptide moiety, such as polyvinyl acetal resin, to enhance adhesion and proliferation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to produce iPS cells by recovering suspended somatic cells in another container, then the production process can be completed, but the operation becomes complicated and time-consuming
Solution Approach 1:
The invention extracts and removes the problematic step of recovering suspended somatic cells in another container from the production process. By using a cell scaffold that selectively adheres only to reprogrammed iPS cells, the method eliminates the need for complex cell recovery operations, thereby simplifying the overall production process and reducing operational complexity.
Solution Approach 2:
The cell scaffold acts as an intermediary element that mediates between the somatic cells and the culture environment. It provides a selective adhesion surface that distinguishes adhered cells (which will become iPS cells) from suspended cells, enabling simplified processing without requiring complex recovery steps in separate containers.
2Manufacturing precision
If conventional methods are used without selective adhesion, then the production process is simpler in setup, but the quality of obtained iPS cells is insufficient with low TRA-1-60 expression
Solution Approach 1:
The invention applies local quality by creating a heterogeneous cell population where only adhered cells on the cell scaffold undergo reprogramming to become high-quality iPS cells with high TRA-1-60 expression. The cell scaffold provides a localized environment that promotes selective adhesion and subsequent reprogramming, ensuring high manufacturing precision for the desired cell quality while maintaining efficient production timing.
3Reliability
If the production process includes multiple steps for cell recovery and re-seeding, then cell quality can be maintained, but the production time increases significantly
Solution Approach 1:
The invention implements preliminary action by pre-coating the culture container with a cell scaffold that is specifically designed to adhere only to reprogrammed iPS cells. This preliminary preparation eliminates the need for subsequent cell recovery and re-seeding steps, as the scaffold is already in place to selectively retain high-quality iPS cells throughout the reprogramming process, thereby maintaining quality consistency while significantly reducing production time.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the easy production of high-quality iPS cells with enhanced TRA-1-60 expression in a shorter timeframe, reducing the need for complex operations and lowering production costs by minimizing viral vector residual amounts.
Implementation Method 1
a removal step of removing suspended somatic cells without adhering to the cell scaffold
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
Provided is a production method for induced pluripotent stem cells by which induced pluripotent stem cells having favorable quality can be easily obtained in a short period of time. A production method for induced pluripotent stem cells according to the present invention includes, in the stated order: a seeding step of seeding somatic cells on a cell culture substrate including a cell scaffold; a removal step of removing suspended somatic cells without adhering to the cell scaffold; and an introducing step of introducing a reprogramming factor into somatic cells adhering to the cell scaffold.